The progress of the soluble suppression of tumorigenicity 2 (sST2) in atrial fibrillation

被引：5
|
作者：
Liu, Jia-Hui [1 ]
Han, Qian-Feng [1 ]
Mo, De-Gang [1 ]
机构：
[1] Shandong First Med Univ, Liaocheng Peoples Hosp, Dept Cardiol, Liaocheng 252000, Shandong, Peoples R China
来源：
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY | 2022年 / 65卷 / 03期
关键词：
D O I：
10.1007/s10840-022-01346-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：591 / 592
页数：2
相关论文
共 50 条
  • [21] Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
    Cui, Yameng
    Qi, Xin
    Huang, Anan
    Li, Jiao
    Hou, Wenguang
    Liu, Keqiang
    MEDICAL SCIENCE MONITOR, 2018, 24 : 5139 - 5146
  • [22] sST2 and Galectin-3 genotyping in patients with persistent atrial fibrillation
    Ruth Saez-Maleta
    Ana Merino-Merino
    Simon Gundin-Menendez
    Ricardo Salgado-Aranda
    Daniel AlKassam-Martinez
    Virginia Pascual-Tejerina
    Javier Martin-Gonzalez
    Javier Garcia-Fernandez
    Jose-Angel Perez-Rivera
    Molecular Biology Reports, 2021, 48 : 1601 - 1606
  • [23] sST2 and Galectin-3 genotyping in patients with persistent atrial fibrillation
    Saez-Maleta, Ruth
    Merino-Merino, Ana
    Gundin-Menendez, Simon
    Salgado-Aranda, Ricardo
    AlKassam-Martinez, Daniel
    Pascual-Tejerina, Virginia
    Martin-Gonzalez, Javier
    Garcia-Fernandez, Javier
    Perez-Rivera, Jose-Angel
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (02) : 1601 - 1606
  • [24] Predictive value of soluble suppression of tumorigenicity 2 in atrial fibrillation: a systematic review and meta-analysis
    Chen, Pengfei
    Zhang, Jie
    Du, Jianpeng
    Shi, Dazhuo
    Zhang, He
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [25] Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation
    Tan, Ruopeng
    Yu, Haixu
    Han, Xu
    Liu, Yang
    Yang, Xiaolei
    Xia, Yun-Long
    Yin, Xiaomeng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [26] Association of Soluble Suppression of Tumorigenicity 2 with New-Onset Atrial Fibrillation in Acute Myocardial Infarction
    Chen, Lei
    Chen, Wensu
    Shao, Yameng
    Zhang, Min
    Li, Zhi
    Wang, Zhirong
    Lu, Yuan
    CARDIOLOGY, 2022, 147 (04) : 381 - 388
  • [27] Relation between soluble suppression of tumorigenicity 2 (sST2) and brain natriuretic peptide (BNP) in healthy pediatric subjects: from birth through adulthood
    Caselli, C.
    Ragusa, R. R.
    Cantinotti, C. M.
    D'Amico, D. A. A.
    Storti, S. S.
    Cabiati, C. M.
    Clerico, A.
    Federico, G.
    Trivella, M. G.
    Del Ry, S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 797 - 797
  • [28] Role of sST2 in predicting recurrence of atrial fibrillation after radiofrequency catheter ablation
    Liu, Hailei
    Wang, Kexin
    Lin, YongPing
    Liang, Xichen
    Zhao, Shuai
    Li, Mingfang
    Chen, Minglong
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (11): : 1235 - 1241
  • [29] The value of soluble suppression of tumorigenesis-2 (sST2) in the maintenance of hemodialysis patients with heart failure
    Zhou, X.
    Yi, F.
    Peng, L.
    Jiang, J.
    Lan, L.
    HIPPOKRATIA, 2022, 26 (01) : 19 - 24
  • [30] Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T
    Dispenzieri, Angela
    Gertz, Morie A.
    Saenger, Amy
    Kumar, Shaji K.
    Lacy, Martha Q.
    Buadi, Francis K.
    Dingli, David
    Leung, Nelson
    Zeldenrust, Steven
    Hayman, Suzanne R.
    Kapoor, Prashant
    Grogan, Martha
    Hwa, Lisa
    Russell, Stephen J.
    Go, Ronald S.
    Rajkumar, S. Vincent
    Kyle, Robert A.
    Jaffe, Allan
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) : 524 - 528
12345